ALL vs MGRX · P/E 4.9, rev $18.60B vs rev $456.0K
The Allstate Corporation (ALL) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the ALL and MGRX stock pages for the full models.
Not investment advice.